GLP-1R activation alters performance in cognitive tasks in a sex-dependent manner.

Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Taylor S TrammellDevon L Graham

Abstract

The activation of the glucagon-like peptide-1 receptor (GLP-1R) has been purported to have antidepressant-like and cognitive-enhancing effects. Many people suffering from major depressive disorder (MDD) also experience deficits in cognition. While currently approved antidepressant pharmacotherapies can alleviate the mood symptoms in some patients, they do not treat the cognitive ones. We tested whether systemic administration of a GLP-1R agonist would alter location discrimination, a cognitive task that is diminished in humans with MDD. Male and female laboratory mice (6-8 weeks old, N = 6-14/sex) were trained in a touchscreen operant task of location discrimination. Upon reaching baseline criterion, mice were administered vehicle or a GLP-1R agonist, Exendin-4, systemically prior to testing in probe trials of varying difficulty. Following GLP-1R activation, males showed modest yet non-significant performance in the location discrimination task. Females, however, showed enhanced performance during the most difficult probe tests following Exendin-4 administration. GLP-1R activation appears to enhance overall performance in the location discrimination task and does so in a sex- and difficulty-dependent manner. These preliminary y...Continue Reading

References

Feb 21, 2002·Progress in Neuro-psychopharmacology & Biological Psychiatry·Christian MöllerMarkus Heilig
Aug 20, 2003·Nature Medicine·Matthew J DuringColin N Haile
Aug 9, 2005·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·E J M BiermanA T F Beekman
May 4, 2006·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Rishi K BhallaJames T Becker
Apr 30, 2009·Nature Reviews. Neuroscience·Sonia J LupienChristine Heim
May 12, 2009·Journal of Affective Disorders·Lisa M McDermott, Klaus P Ebmeier
Jul 27, 2011·Trends in Neurosciences·Michael A Yassa, Craig E L Stark
Apr 3, 2012·Physiology & Behavior·Kevin ErregerAurelio Galli
Apr 12, 2012·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Suzanne L DicksonKarolina P Skibicka
Oct 24, 2012·Molecular Psychiatry·D L GrahamG D Stanwood
Dec 12, 2012·Psychoneuroendocrinology·Emil EgeciogluElisabet Jerlhag
Oct 31, 2013·Psychological Medicine·P L RockA D Blackwell
Jun 7, 2014·International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience·Ebrahim RajabAmer Kamal
Feb 6, 2016·Nature·Heidi Ledford
Oct 5, 2017·Physiology & Behavior·Debra A BangasserMadeleine Salvatore
Feb 8, 2018·Peptides·Emily BrownJohn P Wilding
Jun 15, 2017·Biomedical Engineering Letters·Jinsick ParkDong Pyo Jang
Jan 20, 2020·Progress in Neuro-psychopharmacology & Biological Psychiatry·Adriano José Maia Chaves FilhoDanielle S Macedo
Mar 15, 2020·The Journal of Comparative Neurology·Devon L GrahamGregg D Stanwood

❮ Previous
Next ❯

Citations

Apr 18, 2021·Neurotoxicology and Teratology·Devon L GrahamGregg D Stanwood
May 19, 2021·Pharmacological Reports : PR·Jan Detka, Katarzyna Głombik

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Biology of GLP-1

Glucagon-like peptide 1 (GLP-1) plays a role in glucose metabolism, energy homeostasis, and inflammation suppression. GLP-1 receptor signaling has been shown to impact cardiovascular function. This feed focuses on the role of GLP-1 and GLP-1 receptor agonists on cardiovascular biology.